Invenia ABUS 2.0

Automated Breast Ultrasound

Detecting more cancer

GE Healthcare offers the only FDA-approved ultrasound supplemental screening technology that is specifically designed for detecting cancer in dense breast tissue.

Compared to mammography alone, Invenia ABUS 2.0 imaging looks differently at dense breast tissue, providing a comprehensive view of the breast. This technology has demonstrated a 55% relative increase in invasive cancer detection for these women.

下載附檔